roivant sciences ltd glp-1 receptor agonist medications Mapping the effectiveness and risks of agonists S-1/A

72 Recent research has shown that DPP4-expressing fibroblasts contribute to collagen accumulation in cutaneous scars, and inhibiting DPP4 reduces scar formation in a rat model of wound healing

37% of GLP-1 users have heard of Compounded* Liraglutide with B12 as an alternative, with awareness highest among millennials (47%)

Over the past few years, due to both appropriate and inappropriate use, the demand for and use of GLP-1 and GIP/GLP-1 receptor agonists have increased substantially, leaving drug manufacturers struggling to keep their supply sufficient to meet these increased needs

New patient-tracking metrics: Craving trajectories, relapse-risk dashboards, and dosing adherence signals will become essential data layers

Weight loss can be a complex undertaking, especially as we face physical, mental, and emotional barriers to achieving our desired goal